Advancing the Science

Mayo Clinic Medical Science Blog – an eclectic collection of research- and research education-related stories: feature stories, mini news bites, learning opportunities, profiles and more from Mayo Clinic.

Items Tagged ‘idiopathic pulmonary fibrosis’

September 21, 2021 · Leave a Comment

Antifibrotics may extend lives for patients with IPF

By Elizabeth Zimmermann Elizabeth Zimmermann (@elizabethzimmermann)

Mayo Clinic researchers recently learned that patients who are taking antifibrotic drugs for idiopathic pulmonary fibrosis (IPF) have a better chance of survival after a respiratory-related hospitalization compared to patients not receiving these medications. The study, which was supported by Three Lakes Foundation, was published recently in BMC Pulmonary Medicine. Read Three Lakes news release. […]

View full entry Comment on this

Tags: Andrew Limper, Center for the Science of Health Care Delivery, idiopathic pulmonary fibrosis, OptumLabs


August 23, 2021 · Leave a Comment

Mayo Clinic Research in the news — 8/23/2021

By Advancing the Science contributor Advancing the Science contributor (@advancingthescience)

In the last 15 days or so, COVID-19 related news continues to dominate the headlines on the research front. However, Mayo Clinic’s expertise also was evident on topics from inclusivity in clinical trials, a geological connection in kidney stones, life extending therapies and better understanding of contributors to dementia, stroke and death. Read on for […]

View full entry Comment on this

Tags: brain, clinical trials, cognitive impairment, COVID-19, dementia, diversity, health disparities, hypertension, idiopathic pulmonary fibrosis, immune system, kidney stones, knee replacement


June 15, 2021 · Leave a Comment

Transforming medicine for patients with respiratory diseases

By Elizabeth Zimmermann Elizabeth Zimmermann (@elizabethzimmermann)

The Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery provides a unique service for Mayo Clinic. Embedded in the medical practice, its objective is to transform the practice of medicine – from the inside out. Center researchers work within multidisciplinary teams to identify areas for improvement within […]

View full entry Comment on this

Tags: Aahd Kubbara, acute respiratory illness, Alanna Chamberlain, Andrew Limper, Ann Vu, antifungal, biomedical research, Cassie Kennedy, Center for the Science of Health Care Delivery, chronic obstructive pulmonary disease, COPD, COVID-19


February 8, 2021 · Leave a Comment

Mayo Clinic Research in the news — 2/8/2021

By Elizabeth Zimmermann Elizabeth Zimmermann (@elizabethzimmermann)

In the week’s news, you can find expertise from Mayo Clinic clinicians and researchers on a range of topics, including several different heart conditions, a blood test for Alzheimer’s, cancer, disparities in diabetes care, and of course COVID-19. Expertise from a Mayo Clinic International consultant is also highlighted, along with Michael Camilleri, M.D., who received […]

View full entry Comment on this

Tags: Alzheimer's disease, artificial intelligence, Bart Demaerschalk, blood cancer, blood disease, blood test, breast cancer, cardiology, cardiovascular disease, caregivers, Center for Digital Health, Center for the Science of Health Care Delivery


September 20, 2019 · Leave a Comment

Good news about the effectiveness of antifibrotics for IPF

By Elizabeth Zimmermann Elizabeth Zimmermann (@elizabethzimmermann)

In a recent study published in the American Journal of Respiratory and Critical Care, a research team led by Andrew Limper, M.D., a pulmonology and critical care physician at Mayo Clinic, evaluated the effectiveness of pirfenidone and nintedanib for patients with idiopathic pulmonary fibrosis. The researchers reported “the medications had an association with a reduced […]

View full entry Comment on this

Tags: Andrew Limper, Center for the Science of Health Care Delivery, clinical trials, idiopathic pulmonary fibrosis, OptumLabs


Contact Us · Privacy Policy